Search - tctmd.com

Displaying 101 - 120 of 904

Sort: Relevancy | Date

News Conference News TCT 2020

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

L.A. McKeown

October 17, 2020

Presentation TCT 2020

OPTIMIZE: A Randomized Trial of a Novel, Ultra Low Profile Fixed-Wire DES

Presenter: Dean Kereiakes

October 17, 2020

The OPTIMIZE IDE: TrialProspective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed-Wire and Rapid-Exchange Delivery Systems and a Novel Bioresorbable Drug Carrier

Presentation TCT 2020

OPTIMIZE IDE: Trial Prospective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed-Wire and Rapid-Exchange Delivery Systems and a Novel Bioresorbable Drug Carrier

Presenter: Dean J. Kereiakes

October 17, 2020

Presentation TCT 2020

COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Coated Stent With 14 Days DAPT in High-Bleeding Risk Patients

Presenter: Robert Byrne

October 17, 2020

Presentation TCT 2020

The HOST-Reduce-Polytech-ACS trial: Durable Polymer versus Biodegradable Polymer Drug-Eluting Stents after percutaneous coronary intervention in patients with Acute Coronary Syndrome

Presenter: Hyo-Soo Kim

October 17, 2020

Presentation TCT 2020

HOST-REDUCE-POLYTECH-ACS: A Randomized Trial of Durable Polymer vs Bioabsorbable Polymer DES in Patients With Acute Coronary Syndromes

Presenter: Hyo-Soo Kim

October 17, 2020

News Conference News TCT 2020

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Shelley Wood

October 17, 2020

Presentation TCT 2020

My Top 5 Tips and Tricks for Successful Use of Physiologic Assessment in Bifurcation PCI

Presenter: Bon-Kwon Koo

October 17, 2020

Debate: What Should Be the Default Strategy for a True Left Main Bifurcation PCI? - Provisional Stenting Should Be the Gold Standard, and EBC-MAIN Will Prove It!

Presentation TCT 2020

Provisional Stenting Should Be the Gold Standard, and EBC-MAIN Will Prove It!

Presenter: David Hildick-Smith

October 17, 2020

Presentation TCT 2020

2020 Clinical Data Updates on Bifurcation PCI Techniques

Presenter: Gennaro Sardella

October 17, 2020

Presentation TCT 2020

Debate: What Should Be the Default Strategy for a True Left Main Bifurcation PCI? - DK-Crush Outperforms Both Provisional and Culotte Stenting!

Presenter: Emmanouil Brilakis

October 17, 2020

News Conference News TCT 2020

FFR Insights Before and After PCI: Fresh Food for Thought

Caitlin E. Cox

October 16, 2020

News Conference News TCT 2020

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

Todd Neale

October 16, 2020

Presentation TCT 2020

The Conundrum of Coronary Access and Commissural Alignment After TAVR: Clinical Relevance and Procedural Considerations

Presenter: Gilbert Tang

October 16, 2020

Presentation TCT 2020

TARGET FFR - Physiology-Guided Optimization of PCI: A Randomized Controlled Trial

Presenter: Damien Collison

October 16, 2020

Presentation TCT 2020

Fractional Flow Reserve Derived from Computed Tomography Coronary Angiography in the Assessment & Management of Stable Chest Pain

Presenter: Nick Curzen

October 16, 2020

Presentation TCT 2020

When, Why, and How to Evaluate the Microvasculature in the Cath Lab

Presenter: Tom Ford

October 16, 2020

Presentation TCT 2020

Rationale and Techniques for Post-PCI Coronary Physiology Assessment

Presenter: Allen Jeremias

October 16, 2020

Presentation TCT 2020

It’s All About the Plaque – Plaque Burden and Morphology Are the Most Important Predictors!

Presenter: David Erlinge

October 16, 2020

Presentation TCT 2020

Clopidogrel for Most!

Presenter: John Bittl

October 15, 2020

Advertisement

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

OPTIMIZE: A Randomized Trial of a Novel, Ultra Low Profile Fixed-Wire DES

OPTIMIZE IDE: Trial Prospective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed-Wire and Rapid-Exchange Delivery Systems and a Novel Bioresorbable Drug Carrier

COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Coated Stent With 14 Days DAPT in High-Bleeding Risk Patients

The HOST-Reduce-Polytech-ACS trial: Durable Polymer versus Biodegradable Polymer Drug-Eluting Stents after percutaneous coronary intervention in patients with Acute Coronary Syndrome

HOST-REDUCE-POLYTECH-ACS: A Randomized Trial of Durable Polymer vs Bioabsorbable Polymer DES in Patients With Acute Coronary Syndromes

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

My Top 5 Tips and Tricks for Successful Use of Physiologic Assessment in Bifurcation PCI

Provisional Stenting Should Be the Gold Standard, and EBC-MAIN Will Prove It!

2020 Clinical Data Updates on Bifurcation PCI Techniques

Debate: What Should Be the Default Strategy for a True Left Main Bifurcation PCI? - DK-Crush Outperforms Both Provisional and Culotte Stenting!

FFR Insights Before and After PCI: Fresh Food for Thought

Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains

The Conundrum of Coronary Access and Commissural Alignment After TAVR: Clinical Relevance and Procedural Considerations

TARGET FFR - Physiology-Guided Optimization of PCI: A Randomized Controlled Trial

Fractional Flow Reserve Derived from Computed Tomography Coronary Angiography in the Assessment & Management of Stable Chest Pain

When, Why, and How to Evaluate the Microvasculature in the Cath Lab

Rationale and Techniques for Post-PCI Coronary Physiology Assessment

It’s All About the Plaque – Plaque Burden and Morphology Are the Most Important Predictors!

Clopidogrel for Most!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content